
The Epistane Analysis is a targeted laboratory test designed to confirm the identity and determine the amount of epistane in oral dosage forms and raw active pharmaceutical ingredient (API) powders.
The analysis is suitable for tablets and capsules, with results reported in milligrams per individual dosage unit. Raw API powders can be evaluated by percentage content, with optional purity reporting in % (m/m).
Epistane, also known as methylepitiostanol or 2,3-thioepoxy madol, is a synthetic, orally active anabolic-androgenic steroid structurally related to dihydrotestosterone (DHT). It is a 17α-methylated derivative of epitiostanol and interacts with androgen receptors, producing anabolic and androgenic effects.
Epistane has been identified in products marketed as dietary or performance-enhancing supplements. Scientific studies have also associated its use with a risk of liver injury, including cholestasis.
The following optional laboratory services are available:
